Prebiotics for the prevention of hyperbilirubinaemia in neonates
Referencias
Additional references
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114(1):297–316. [PUBMED: 15231951]
Armanian AM, Sadeghnia A, Hoseinzadeh M, Mirlohi M, Feizi A, Salehimehr N, et al. The effect of neutral oligosaccharides on reducing the incidence of necrotizing enterocolitis in preterm infants: a randomized clinical trial. International Journal of Preventive Medicine 2014;5(11):1387‐95. [PUBMED: 25538834]
Armanian AM, Barekatain B, Hoseinzadeh M, Salehimehr N. Prebiotics for the management of hyperbilirubinemia in preterm neonates. Journal of Maternal‐fetal & Neonatal Medicine 2016;29(18):3009‐13. [DOI: 10.3109/14767058.2015.1113520; PUBMED: 26513278]
Armanian AM, Sadeghnia A, Hoseinzadeh M, Mirlohi M, Feizi A, Salehimehr N, et al. The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: a randomized clinical trial. Journal of Research in Pharmacy Practice 2016;5(1):27‐34. [DOI: 10.4103/2279‐042X.176558; PUBMED: 26985433]
Bisceglia M, Indrio F, Riezzo G, Poerio V, Corapi U, Raimondi F. The effect of prebiotics in the management of neonatal hyperbilirubinaemia. Acta Paediatrica 2009;98(10):1579‐81. [DOI: 10.1111/j.1651‐2227.2009.01387.x; PUBMED: 19555446]
Boluyt N, Tjosvold L, Lefebvre C, Klassen TP, Offringa M. Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE. Archives of Pediatrics & Adolescent Medicine 2008;162(2):111–6. [DOI: 10.1001/archpediatrics.2007.40; PUBMED: 18250233]
Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C, Tilford JM. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988‐2005. Pediatrics 2009;123(2):524‐32. [DOI: 10.1542/peds.2007‐2915; PUBMED: 19171618]
Canadian Pediatric Society. Guidelines for detection, management and prevention of hyperbilirubinaemia in term and late preterm newborn infants (35 or more weeks' gestation) ‐ Summary. Paediatrics & Child Health 2007;12(5):401‐18. [PUBMED: 19030400]
Cetinkursun S, Demirbag S, Cincik M, Baykal B, Gunal A. Effects of phototherapy on newborn rat testicles. Archives of Andrology 2006;52(1):61‐70. [DOI: 10.1080/01485010500302089; PUBMED: 16338871]
Cummings JH, Macfarlane GT. Gastrointestinal effects of prebiotics. British Journal of Nutrition 2002;87(Suppl 2):S145‐51. [DOI: 10.1079/BJNBJN/2002530; PUBMED: 12088511]
Gartner LM. Breastfeeding and jaundice. Journal of Perinatology 2001;21(Suppl 1):S25‐9. [DOI: 10.1038/sj.jp.7210629; PUBMED: 11803412]
Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition 1995;125(6):1401.
GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 21 June 2017. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. handbook.cochrane.org.
Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R. Effects of probiotic and prebiotic on gastrointestinal motility in newborns. Journal of Physiology and Pharmacology 2009;60(Suppl 6):27‐31. [PUBMED: 20224148]
Kaplan M, Bromiker R, Hammerman C. Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium?. Neonatology 2011;100(4):354‐62. [DOI: 10.1159/000330055; PUBMED: 21968213]
Konickova R, Jiraskova A, Zelenka J, Leseticky L, Sticha M, Vitek L. Reduction of bilirubin ditaurate by the intestinal bacterium Clostridium perfringens . Acta Biochimica Polonica 2012;59(2):289‐92. [PUBMED: 22540115]
Lauer BJ, Spector ND. Hyperbilirubinemia in the newborn. Pediatrics in Review 2011;32(8):341‐9. [DOI: 10.1542/pir.32‐8‐341; PUBMED: 21807875]
Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. New England Journal of Medicine 2008;358(9):920–8. [DOI: 10.1056/NEJMct0708376; PUBMED: 18305267]
Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant ≥ 35 weeks’ gestation: an update with clarifications. Pediatrics 2009;124(4):1193‐8. [DOI: 10.1542/peds.2009‐0329; PUBMED: 19786452]
Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. Journal of Perinatology 2012;32(9):660‐4. [DOI: 10.1038/jp.2012.71; PUBMED: 22678141]
Modi N, Uthaya S, Fell J, Kulinskaya E. A randomized, double‐blind, controlled trial of the effect of prebiotic oligosaccharides on enteral tolerance in preterm infants. Pediatric Research 2010;68(5):440‐5. [DOI: 10.1203/PDR.0b013e3181f1cd59; PUBMED: 20639792]
Okumura A, Kidokoro H, Shoji H, Nakazawa T, Mimaki M, Fujii K, et al. Kernicterus in preterm infants. Pediatrics 2009;123(6):e1052‐e8. [DOI: 10.1542/peds.2008‐2791; PUBMED: 19433515]
Oozeer R, van Limpt K, Ludwig T, Amor KB, Martin R, Wind RD, et al. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human‐milk oligosaccharides. American Journal of Clinical Nutrition 2013;98(2):561S‐71S. [DOI: 10.3945/ajcn.112.038893; PUBMED: 23824728]
Ramy N, Ghany EA, Alsharany W, Nada A, Darwish RK, Rabie WA, et al. Jaundice, phototherapy and DNA damage in full‐term neonates. Journal of Perinatology 2016;36(2):132‐6. [DOI: 10.1038/jp.2015.166; PUBMED: 26583945]
Rao S, Srinivasjois R, Patole S. Prebiotic supplementation in full‐term neonates: a systematic review of randomized controlled trials. Archives of Pediatrics & Adolescent Medicine 2009;163(8):755‐64. [DOI: 10.1001/archpediatrics.2009.94; PUBMED: 19652109]
Riskin A, Hochwald O, Bader D, Srugo I, Naftali G, Kugelman A, et al. The effects of lactulose supplementation to enteral feedings in premature infants: a pilot study. Journal of Pediatrics 2010;156(2):209‐14. [DOI: 10.1016/j.jpeds.2009.09.006; PUBMED: 19879595]
Roll EB, Christensen T. Formation of photoproducts and cytotoxicity of bilirubin irradiated with turquoise and blue phototherapy light. Acta Paediatrica 2005;94(10):1448‐54. [DOI: 10.1080/08035250510032655; PUBMED: 16263632]
Rosenstein BS, Ducore JM. Enhancement by bilirubin of DNA damage induced in human cells exposed to phototherapy light. Pediatric Research 1984;18(1):3‐6. [PUBMED: 6701032]
Sato H, Uchida T, Toyota K, Kanno M, Hashimoto T, Watanabe M, et al. Association of breast‐fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G> A (G71R) mutation becomes a risk factor under inadequate feeding. Journal of Human Genetics 2013;58(1):7‐10. [DOI: 10.1038/jhg.2012.116; PUBMED: 23014115]
Schünemann H, Brożek J, Guyatt G, Oxman A, editors. GRADE Working Group. GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. https://gdt.gradepro.org/app/handbook/handbook.html.[Updated October 2013].
Sherman PM, Cabana M, Gibson GR, Koletzko BV, Neu J, Veereman‐Wauters G, et al. Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27‐28, 2008. Journal of Pediatrics 2009;155(5):S61‐70. [DOI: 10.1016/j.jpeds.2009.08.022; PUBMED: 19840609]
Srinivasjois R, Rao S, Patole S. Prebiotic supplementation in preterm neonates: updated systematic review and meta‐analysis of randomised controlled trials. Clinical Nutrition (Edinburgh, Scotland) 2013;32(6):958‐65. [DOI: 10.1016/j.clnu.2013.05.009; PUBMED: 23786897]
Tatli MM, Minnet C, Kocyigit A, Karadag A. Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates. Mutation Research 2008;654(1):93‐5. [DOI: 10.1016/j.mrgentox.2007.06.013; PUBMED: 18534897]
Tyson JE, Pedroza C, Langer J, Green C, Morris B, Stevenson D, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns?. Journal of Perinatology 2012;32(9):677‐84. [DOI: 10.1038/jp.2012.64; PUBMED: 22652561]
Vitek L, Majer F, Muchova L, Zelenka J, Jiraskova A, Branny P, et al. Identification of bilirubin reduction products formed by Clostridium perfringens isolated from human neonatal fecal flora. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 2006;833(2):149‐57. [DOI: 10.1016/j.jchromb.2006.01.032; PUBMED: 16504607]
Westerbeek E, Hensgens R, Mihatsch W, Boehm G, Lafeber H, Van Elburg R. The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants. Acta Paediatrica 2011;100(11):1426‐31. [DOI: 10.1111/j.1651‐2227.2011.02295.x; PUBMED: 21449921]
Xiong T, Qu Y, Cambier S, Mu D. The side effects of phototherapy for neonatal jaundice. What do we know? What should we do?. European Journal of Pediatrics 2011;170(10):1247‐55. [DOI: 10.1007/s00431‐011‐1454‐1; PUBMED: 21455834]
Yahia S, Shabaan AE, Gouida M, El‐Ghanam D, Eldegla H, El‐Bakary A, et al. Influence of hyperbilirubinemia and phototherapy on markers of genotoxicity and apoptosis in full‐term infants. European Journal of Pediatrics 2015;174(4):459‐64. [DOI: 10.1007/s00431‐014‐2418‐z; PUBMED: 25209224]
Figuras y tablas -
Figure 1
Guidelines for phototherapy in infants at ≥ 35 weeks' gestation.
(American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297.)
Figuras y tablas -
Figure 2
Suggested guidelines for initiating phototherapy or exchange transfusion in premature infants.
(Maisels MJ, Watchko JF, Bhutani VK, et al. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. Journal of Perinatology 2012;32:660‐664.)
